ClinicalTrials.Veeva

Menu

Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status

Enrolling

Conditions

Myopotential Interference
Subcutaneous ICD

Treatments

Device: Smart Pass OFF
Device: Smart Pass ON

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05766943
00117025

Details and patient eligibility

About

This study is enrolling participants who are already implanted with a S-ICD device ( subcutaneous ICD), and are undergoing a routine outpatient clinic follow up appointment to have their S-ICD checked. The aim of the study is to see if a feature in the device can recognize muscle movement and differentiate movement from irregular heart signals. The study involves doing some simple arm exercises while collecting device data, both with this feature turn on and then with it turned off. Participants will be randomized to either have the feature turned on or off initially then it will be programmed the alternative way and the same exercise testing will be repeated. The study will involve just one visit.

Full description

This study is enrolling participants who are already implanted with a S-ICD device ( subcutaneous ICD), and are undergoing a routine outpatient clinic follow up appointment to have their S-ICD checked. The aim of the study is to see if a feature in the device can recognize muscle movement and differentiate movement from irregular heart signals. The study involves doing some simple arm exercises while collecting device data, both with this feature turn on and then with it turned off. Participants will be randomized to either have the feature turned on or off initially, then it will be programmed the alternative way and the same exercise testing will be repeated. The study will involve just one visit. Following this visit study participation is complete.

Enrollment

71 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years of age
  • Implanted EMBLEM S-ICD (Model A 209 and Model A 219, Boston Scientific, St Paul, MN, USA)

Exclusion criteria

  • Less than 18 years of age
  • Hemodynamically unstable
  • Inability to preform TET due to orthopedic issues or cognitive impairment

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

71 participants in 2 patient groups, including a placebo group

Smart Pass ON
Active Comparator group
Description:
Smart Pass filter will be programmed ON in the S-ICD while performing exercise testing.
Treatment:
Device: Smart Pass ON
Smart Pass OFF
Placebo Comparator group
Description:
Smart Pass filter will be programmed OFF in the S-ICD while performing exercise testing.
Treatment:
Device: Smart Pass OFF

Trial contacts and locations

1

Loading...

Central trial contact

Debi Everidge; Kavin Panneerselvam

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems